Roberts Lesley M, Pattison Helen, Roalfe Andrea, Franklyn Jayne, Wilson Sue, Hobbs F D Richard, Parle James V
Department of Primary Care and General Practice, University of Birmingham, Edgbaston, Birmingham, United Kingdom.
Ann Intern Med. 2006 Oct 17;145(8):573-81. doi: 10.7326/0003-4819-145-8-200610170-00006.
Widespread use of automated sensitive assays for thyroid hormones and thyroid-stimulating hormone (TSH) has increased identification of mild thyroid dysfunction, especially in elderly patients. The clinical significance of this dysfunction, however, remains uncertain, and associations with cognitive impairment, depression, and anxiety are unconfirmed.
To determine the association between mild thyroid dysfunction and cognition, depression, and anxiety in elderly persons.
Cross-sectional study. Associations were explored through mixed-model analyses.
Primary care practices in central England.
5865 patients 65 years of age or older with no known thyroid disease who were recruited from primary care registers.
Serum TSH and free thyroxine (T4) were measured. Depression and anxiety were assessed by using the Hospital Anxiety and Depression Scale (HADS), and cognitive functioning was established by using the Middlesex Elderly Assessment of Mental State and the Folstein Mini-Mental State Examination. Comorbid conditions, medication use, and sociodemographic profiles were recorded.
295 patients met the criteria for subclinical thyroid dysfunction (127 were hyperthyroid, and 168 were hypothyroid). After confounding variables were controlled for, statistically significant associations were seen between anxiety (HADS score) and TSH level (P = 0.013) and between cognition and both TSH and free T4 levels. The magnitude of these associations lacked clinical relevance: A 50-mIU/L increase in the TSH level was associated with a 1-point reduction in the HADS anxiety score, and a 1-point increase in the Mini-Mental State Examination score was associated with an increase of 50 mIU/L in the TSH level or 25 pmol/L in the free T4 level.
Because of the low participation rate, low prevalence of subclinical thyroid dysfunction, and other unidentified recruitment biases, participants may not be representative of the elderly population.
After the confounding effects of comorbid conditions and use of medication were controlled for, subclinical thyroid dysfunction was not associated with depression, anxiety, or cognition.
甲状腺激素和促甲状腺激素(TSH)自动化敏感检测方法的广泛应用增加了对轻度甲状腺功能障碍的识别,尤其是在老年患者中。然而,这种功能障碍的临床意义仍不确定,其与认知障碍、抑郁和焦虑的关联也未得到证实。
确定老年人轻度甲状腺功能障碍与认知、抑郁和焦虑之间的关联。
横断面研究。通过混合模型分析探索关联。
英格兰中部的基层医疗诊所。
从基层医疗登记册中招募的5865名65岁及以上且无已知甲状腺疾病的患者。
检测血清TSH和游离甲状腺素(T4)。使用医院焦虑抑郁量表(HADS)评估抑郁和焦虑,并使用米德尔塞克斯老年精神状态评估和福尔斯坦简易精神状态检查表确定认知功能。记录合并症、药物使用情况和社会人口学特征。
295名患者符合亚临床甲状腺功能障碍标准(127名甲状腺功能亢进,168名甲状腺功能减退)。在控制混杂变量后,焦虑(HADS评分)与TSH水平之间(P = 0.013)以及认知与TSH和游离T4水平之间存在统计学显著关联。这些关联的程度缺乏临床相关性:TSH水平每升高50 mIU/L,HADS焦虑评分降低1分,简易精神状态检查表评分每增加1分,TSH水平升高50 mIU/L或游离T4水平升高25 pmol/L。
由于参与率低、亚临床甲状腺功能障碍患病率低以及其他未识别的招募偏差,参与者可能不代表老年人群体。
在控制合并症和药物使用的混杂效应后,亚临床甲状腺功能障碍与抑郁、焦虑或认知无关。